Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 16, 2016

14 MS Experimental Therapies You Should Know About

  • MS Research Study and Reports
    /
APRIL 13, 2016 –  BY ANDREIA PEIXOTO  1. ALKS 8700 Alkremes Inc. is developing a novel formulation called ALKS 8700 to treat…
MS Research Study and Reports

April 16, 2016

High Lactate Levels in MS Patients Tied to Disease Progression, Mitochondrial Dysfunction

  • MS Research Study and Reports
    /
MARCH 23, 201 — BY MAGDALENA KEGEL Scientists in recent years have wondered whether a link exists between high lactate levels resulting from…
MS Research Study and Reports

April 16, 2016

Rosacea Appears to Be Linked to Multiple Sclerosis in Women,

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
MARCH 24, 2016  – BY MAGDALENA KEGEL IN NEWS. Rosacea is an inflammatory skin condition affecting mostly fair-skinned individuals. A…
Multiple Sclerosis

April 16, 2016

Natalizumab (Tysabri) Targets Molecule Crucial for Type of B-Cell to Accumulate in the Brain

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Tysabri                                    Tysabri Mice…
MS Drug Therapies

April 15, 2016

Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
− Strong and Sustained Efficacy of TECFIDERA® Supported by Clinical Data and Real-World Evidence – − New ZINBRYTA™ Data Show Impact…
MS Drug Therapies

April 14, 2016

Genentech to Present New Data at AAN Showing Superior Efficacy of Investigational Medicine Ocrelizumab Versus Comparators on Disease Activity and Progression in Two Forms of Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
New analyses showing superior efficacy of ocrelizumab across clinical and subclinical outcomes compared with interferon beta- 1a (Rebif®) in people…
MS Drug Therapies

April 14, 2016

9 Common MS Symptoms

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
By Connie Brichford Reviewed by Cynthia Haines, MD From fatigue to sexual dysfunction, multiple sclerosis can cause a broad array…
Multiple Sclerosis

April 14, 2016

Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis

  • MRI
    /
  • MS Relapse
    /
Robert Zivadinov1,  Cierra N Treu2,  Bianca Weinstock-Guttman3,  Caitlin Turner2, Niels Bergsland1,  Kerri O’Connor2,  Michael G Dwyer1,  Ellen Carl1,  Deepa P…
MRI

April 14, 2016

CANNABINOID USE IN PROGRESSIVE INFLAMMATORY BRAIN DISEASE (CUPID) MRI SUB–STUDY

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Abstract Introduction In progressive Multiple Sclerosis (MS), there is no proven therapy for preventing accumulation of irreversible disability. The pathological substrate…
Alternative therapies and devices for Multiple Sclerosis (MS)

April 14, 2016

Mapping the 12-item multiple sclerosis walking scale in North American multiple sclerosis patients

  • MS Research Study and Reports
    /
Abstract Objective To map the 12-item Multiple Sclerosis Walking Scale (MSWS-12) onto the EuroQol 5-dimension (EQ-5D) health-utility index in multiple sclerosis…
MS Research Study and Reports

Categories

Latest Blog Posts